Delaware | 001-38098 | 54-1956084 |
(State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
11955 Democracy Drive, Suite 1700, Reston, Virginia | 20190 | |
(Address of Principal Executive Offices) | (Zip Code) |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Exhibit Number | Description | |
Press release dated May 3, 2018. |
Appian Corporation | |||
Date: May 3, 2018 | By: | /s/ Mark Lynch | |
Mark Lynch | |||
Chief Financial Officer |
• | Revenue: Subscription revenue was $25.5 million for the first quarter of 2018, up 36% compared to the first quarter of 2017. Total subscriptions, software and support revenue was $27.0 million for the first quarter of 2018, an increase of 26% year over year. Professional services revenue was $24.7 million for the first quarter of 2018, an increase of 46% year over year. Total revenue was $51.7 million for the first quarter of 2018, up 35% compared to the first quarter of 2017. Subscription revenue retention rate was 119% as of March 31, 2018. |
• | Operating loss and non-GAAP operating loss: GAAP operating loss was $(10.2) million for the first quarter of 2018, compared to $(3.5) million for the first quarter of 2017. Non-GAAP operating loss was $(8.0) million for the first quarter of 2018, compared to $(3.5) million for the first quarter of 2017. |
• | Net loss and non-GAAP net loss: GAAP net loss was $(9.6) million for the first quarter of 2018, compared to $(3.4) million for the first quarter of 2017. GAAP net loss per share attributable to common stockholders was $(0.16) for the first quarter of 2018 based on 60.9 million weighted-average shares outstanding, compared to $(0.10) for the first quarter of 2017 based on 34.3 million weighted-average shares outstanding. Non-GAAP net loss was $(7.3) million for the first quarter of 2018, compared to $(3.4) million for the first quarter of 2017. Non-GAAP net loss per share was $(0.12) for the first quarter of 2018, based on 60.9 million basic and diluted shares outstanding, compared to $(0.06) for the first quarter of 2017, based on 52.4 million basic and diluted shares outstanding. |
• | Balance sheet and cash flows: As of March 31 2018, Appian had cash and cash equivalents of $60.9 million. Cash used in operating activities was $(13.8) million for the three months ended March 31, 2018 compared to $3.7 million of cash flow from operating activities for the same period in 2017. |
• | Signed a global agreement with Banco Santander, the largest bank in the Eurozone by market capitalization. Banco Santander will leverage Appian’s platform in the cloud for enterprise process improvement. |
• | Named a leader by Forrester Research, Inc. in the analyst firm’s “The Forrester Wave: Cloud-Based Dynamic Case Management, Q1 2018” report. Appian received the highest score in the “Current Offering” category and among the |
• | Extended a strategic alliance relationship with VASS with executive commitments to grow in new markets and acquire new customers. |
• | Frost & Sullivan named Appian top 2018 Digital Transformation Platform in Life Sciences & Pharmaceuticals for its cloud-based, low code software application platform. |
• | Second Quarter 2018 Guidance: |
◦ | Subscription revenue is expected to be in the range of $25.8 million and $26.0 million, representing year-over-year growth of between 30% and 31%. |
◦ | Total revenue is expected to be in the range of $50.2 million and $50.4 million, representing year-over-year growth of between 16% and 17%. |
◦ | Non-GAAP operating loss is expected to be in the range of $(10.5) million and $(10.1) million. |
◦ | Non-GAAP net loss per share is expected to be in the range of $(0.18) and $(0.17). This assumes 61.4 million weighted average common shares outstanding. |
• | Full Year 2018 Guidance: |
◦ | Subscription revenue is now expected to be in the range of $107.6 million and $108.6 million, representing year-over-year growth of between 30% and 31%. |
◦ | Total revenue is now expected to be in the range of $202.0 million and $205.0 million, representing year-over-year growth of between 14% and 16%. |
◦ | Non-GAAP operating loss is now expected to be in the range of $(38.9) million and $(36.9) million. |
◦ | Non-GAAP net loss per share is now expected to be in the range of $(0.64) and $(0.61). This assumes 61.6 million non-GAAP weighted average common shares outstanding. |
As of March 31, 2018 | As of December 31, 2017 | ||||||
(unaudited) | |||||||
Assets | |||||||
Current assets | |||||||
Cash and cash equivalents | $ | 60,876 | $ | 73,758 | |||
Accounts receivable, net of allowance of $400 | 52,518 | 55,315 | |||||
Deferred commissions, current | 9,247 | 9,117 | |||||
Prepaid expenses and other current assets | 7,094 | 7,032 | |||||
Total current assets | 129,735 | 145,222 | |||||
Property and equipment, net | 3,359 | 2,663 | |||||
Deferred commissions, net of current portion | 11,931 | 12,376 | |||||
Deferred tax assets | 240 | 281 | |||||
Other assets | 533 | 510 | |||||
Total assets | $ | 145,798 | $ | 161,052 | |||
Liabilities and Stockholders’ Equity | |||||||
Current liabilities | |||||||
Accounts payable | $ | 2,713 | $ | 5,226 | |||
Accrued expenses | 7,059 | 6,467 | |||||
Accrued compensation and related benefits | 8,932 | 12,075 | |||||
Deferred revenue, current | 68,753 | 70,165 | |||||
Other current liabilities | 1,419 | 1,182 | |||||
Total current liabilities | 88,876 | 95,115 | |||||
Deferred tax liabilities | 12 | 87 | |||||
Deferred revenue, net of current portion | 17,055 | 18,922 | |||||
Other long-term liabilities | 1,227 | 1,404 | |||||
Total liabilities | 107,170 | 115,528 | |||||
Stockholders’ equity | |||||||
Class A common stock—par value $0.0001; 500,000,000 shares authorized and 18,891,315 shares issued and outstanding as of March 31, 2018; 500,000,000 shares authorized and 13,030,081 shares issued and outstanding as of December 31, 2017 | 2 | 1 | |||||
Class B common stock—par value $0.0001; 100,000,000 shares authorized and 42,318,846 shares issued and outstanding as of March 31, 2018; 100,000,000 shares authorized, 47,569,796 shares issued and outstanding as of December 31, 2017 | 4 | 5 | |||||
Additional paid-in capital | 144,490 | 141,268 | |||||
Accumulated other comprehensive (loss) income | (126 | ) | 439 | ||||
Accumulated deficit | (105,742 | ) | (96,189 | ) | |||
Total stockholders’ equity | 38,628 | 45,524 | |||||
Total liabilities and stockholders’ equity | $ | 145,798 | $ | 161,052 |
Three Months Ended March 31, | |||||||
2018 | 2017 | ||||||
Revenue: | |||||||
Subscriptions, software and support | $ | 26,952 | $ | 21,444 | |||
Professional services | 24,744 | 16,885 | |||||
Total revenue | 51,696 | 38,329 | |||||
Cost of revenue: | |||||||
Subscriptions, software and support | 2,628 | 2,062 | |||||
Professional services | 18,421 | 10,628 | |||||
Total cost of revenue | 21,049 | 12,690 | |||||
Gross profit | 30,647 | 25,639 | |||||
Operating expenses: | |||||||
Sales and marketing | 22,964 | 17,003 | |||||
Research and development | 9,870 | 7,300 | |||||
General and administrative | 8,060 | 4,849 | |||||
Total operating expenses | 40,894 | 29,152 | |||||
Operating loss | (10,247 | ) | (3,513 | ) | |||
Other (income) expense: | |||||||
Other (income), net | (918 | ) | (499 | ) | |||
Interest expense | 13 | 256 | |||||
Total other (income) | (905 | ) | (243 | ) | |||
Net loss before income taxes | (9,342 | ) | (3,270 | ) | |||
Income tax expense | 211 | 125 | |||||
Net loss | (9,553 | ) | (3,395 | ) | |||
Accretion of dividends on convertible preferred stock | — | 214 | |||||
Net loss attributable to common stockholders | $ | (9,553 | ) | $ | (3,609 | ) | |
Net loss per share attributable to common stockholders: | |||||||
Basic and diluted | $ | (0.16 | ) | $ | (0.10 | ) | |
Weighted average common shares outstanding: | |||||||
Basic and diluted | 60,850,521 | 34,274,718 |
Three Months Ended March 31, | |||||||
2018 | 2017 | ||||||
Cost of revenue | |||||||
Subscriptions, software and support | $ | 110 | $ | — | |||
Professional services | 220 | — | |||||
Operating expenses | |||||||
Sales and marketing | 507 | — | |||||
Research and development | 391 | — | |||||
General and administrative | 1,012 | — | |||||
Total stock-based compensation expense | $ | 2,240 | $ | — |
Three Months Ended March 31, | |||||||
2018 | 2017 | ||||||
Cash flows from operating activities: | |||||||
Net loss | $ | (9,553 | ) | $ | (3,395 | ) | |
Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | |||||||
Depreciation and amortization | 268 | 219 | |||||
Deferred income taxes | 76 | — | |||||
Stock-based compensation | 2,240 | — | |||||
Changes in assets and liabilities: | |||||||
Accounts receivable | 1,932 | 14,304 | |||||
Prepaid expenses and other assets | (1,085 | ) | (2,771 | ) | |||
Deferred commissions | 315 | (741 | ) | ||||
Accounts payable and accrued expenses | (2,161 | ) | (3,860 | ) | |||
Accrued compensation and related benefits | (2,743 | ) | (1,408 | ) | |||
Other current liabilities | 909 | 100 | |||||
Deferred revenue | (3,849 | ) | 1,393 | ||||
Other long-term liabilities | (182 | ) | (136 | ) | |||
Net cash (used in) provided by operating activities | (13,833 | ) | 3,705 | ||||
Cash flows from investing activities: | |||||||
Purchases of property and equipment | (1,036 | ) | (105 | ) | |||
Net cash used in investing activities | (1,036 | ) | (105 | ) | |||
Cash flows from financing activities: | |||||||
Proceeds from exercise of common stock options | 983 | — | |||||
Net cash provided by financing activities | 983 | — | |||||
Effect of foreign exchange rate changes on cash and cash equivalents | 1,004 | 16 | |||||
Net (decrease) increase in cash and cash equivalents | (12,882 | ) | 3,616 | ||||
Cash and cash equivalents, beginning of period | 73,758 | 31,143 | |||||
Cash and cash equivalents, end of period | $ | 60,876 | $ | 34,759 | |||
Supplemental disclosure of cash flow information: | |||||||
Cash paid for interest | $ | 8 | $ | 248 | |||
Cash paid for income taxes | $ | 57 | $ | 54 | |||
Supplemental disclosure of non-cash financing activities: | |||||||
Accretion of dividends on convertible preferred stock | $ | — | $ | 214 | |||
Deferred offering costs included in accounts payable and accrued expenses | $ | — | $ | 1,251 |
Three Months Ended March 31, | |||||||
2018 | 2017 | ||||||
Reconciliation of non-GAAP operating loss: | |||||||
GAAP operating loss | $ | (10,247 | ) | $ | (3,513 | ) | |
Add back: | |||||||
Stock-based compensation expense | 2,240 | — | |||||
Non-GAAP operating loss | $ | (8,007 | ) | $ | (3,513 | ) | |
Reconciliation of non-GAAP net loss: | |||||||
GAAP net loss | $ | (9,553 | ) | $ | (3,395 | ) | |
Add back: | |||||||
Stock-based compensation expense | 2,240 | — | |||||
Non-GAAP net loss | $ | (7,313 | ) | $ | (3,395 | ) | |
Non-GAAP earnings per share: | |||||||
Non-GAAP net loss | $ | (7,313 | ) | $ | (3,395 | ) | |
Non-GAAP weighted average shares used to compute net loss per share attributable to common stockholders, basic and diluted | 60,850,521 | 52,437,876 | |||||
Non-GAAP net loss per share, basic and diluted | $ | (0.12 | ) | $ | (0.06 | ) | |
Reconciliation of non-GAAP net loss per share, basic and diluted: | |||||||
GAAP net loss per share attributable to common stockholders, basic and diluted | $ | (0.16 | ) | $ | (0.10 | ) | |
Add back: | |||||||
Non-GAAP adjustments to net loss per share | 0.04 | 0.04 | |||||
Non-GAAP net loss per share, basic and diluted | $ | (0.12 | ) | $ | (0.06 | ) | |
Reconciliation of non-GAAP weighted average shares outstanding, basic and diluted: | |||||||
GAAP weighted average shares used to compute net loss per share attributable to common stockholders, basic and diluted | 60,850,521 | 34,274,718 | |||||
Add back: | |||||||
Additional weighted average shares giving effect to conversion of preferred stock at the beginning of the period | — | 18,163,158 | |||||
Non-GAAP weighted average shares used to compute net loss per share, basic and diluted | 60,850,521 | 52,437,876 |